论文部分内容阅读
目的分析甘精胰岛素联合瑞格列奈治疗2型糖尿病临床效果。方法选取我院2013年7月至2014年9月收治的2型糖尿病患者90例为研究对象,随机分为2组,对照组给予甘精胰岛素,观察组给予甘精胰岛素联合瑞格列奈进行治疗,比较分析2组临床疗效与患者满意度。结果观察组总有效率为97.78%,对照组为88.89%,差异有统计学意义;观察组护理满意度100%,对照组为91.11%,差异有统计学意义。结论甘精胰岛素联合瑞格列奈用于治疗2型糖尿病,能有效提高患者满意度,帮助患者早日恢复健康,有临床推广价值。
Objective To analyze the clinical effect of insulin glargine combined with repaglinide on type 2 diabetes mellitus. Methods Ninety patients with type 2 diabetes who were admitted to our hospital from July 2013 to September 2014 were selected and randomly divided into two groups. The control group was given insulin glargine, and the observation group was given insulin glargine combined with repaglinide Treatment, comparative analysis of two groups of clinical efficacy and patient satisfaction. Results The total effective rate was 97.78% in the observation group and 88.89% in the control group, the difference was statistically significant; the nursing satisfaction of the observation group was 100% and that of the control group was 91.11%, the difference was statistically significant. Conclusion Glargine and repaglinide can be used to treat type 2 diabetes mellitus, which can effectively improve patient satisfaction and help patients recover soon and have clinical value.